(7S,7aS,9S,14S,14aR)-9-hydroxydodecahydro-7,14-methanodipyrido[1,2-a:1',2'-e][1,5]diazocin-4(6H)-one;(2S,7S,7aR,14S,14aS)-Dodecahydro-2-hydroxy-7,14-methano-2H,11H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-11-one; [2S-(2?,7?,7a?,14?,14a?)]-Dodecahydro-2-hydroxy-7,14-methano-2H,11H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-11-one; 13-Hydroxy-lupanine; 13?-Hydroxy-lupanine; Hydroxy-lupanine; (+)-13-Hydroxylupanine; (+)-13?-Hydroxylupanine; 13-Hydroxylupanin; 13-Hydroxylupanine; 13?-Hydroxy-2-oxosparteine; 13?-Hydroxylupanine; [7S-(7?,7a?,9?,14?,14a?)]-Dodecahydro-2-hydroxy-7,14-methano-2H,11H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-11-one; Hydroxylupanin; Hydroxylupanine; NSC 70827; Oxylupanine
13-Hydroxy Lupanine is a fully characterized chemical compound used as a reference standard of API Lupanine. The standard offered is compliant with regulatory guidelines. 13-Hydroxy Lupanine is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 15358-48-2